NBSE NeuBase Therapeutics Chart, History Price & Graph

a company, which engages in the development of drugs for patients with genetic neurological disorder.

Get AI intraday signals

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading

View a ticker or compare two or three

Compare

Interact to see
Advertisement